SCHEMBL7958566

SCHEMBL7958566

O=C1NC(=S)S/C1=C\c1ccc(OCc2ccc3ccccc3c2)cc1

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 3/20 0.77
MMP3 P08254 2/20 0.77
CTSD P07339 4/20 0.69
MEN1 O00255 1/20 0.68
PIM1 P11309 1/20 0.68
RAB9A P51151 1/20 0.68
KMT2A Q03164 1/20 0.68
ADAMTS5 Q9UNA0 3/20 0.65
HPGD P15428 3/20 0.62
PTPN1 P18031 2/20 0.62
POLB P06746 1/20 0.62
MAOA P21397 1/20 0.62
MAOB P27338 1/20 0.62
PTP4A3 O75365 1/20 0.59
MGAM O43451 1/20 0.59
GAA P10253 1/20 0.59
SI P14410 1/20 0.59
MGAM2 Q2M2H8 1/20 0.59
PTGS2 P35354 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958571 1.00 MMP13 (0.77) MMP13MMP3CTSDMEN1PIM1
SCHEMBL1248974 0.87 MMP13 (1.00) MMP13MMP3CTSDMEN1KMT2A
SCHEMBL1248973 0.87 MMP13 (1.00) MMP13MMP3CTSDMEN1KMT2A
SCHEMBL4050544 0.87 MMP13 (0.91) MMP13MMP3CTSDMEN1KMT2A
SCHEMBL12892045 0.87 MMP13 (1.00) MMP13MMP3CTSDMEN1KMT2A
SCHEMBL7975010 0.85 MMP13 (0.81) MMP13MMP3CTSDADAMTS5HPGD
SCHEMBL7975012 0.85 MMP13 (0.81) MMP13MMP3CTSDADAMTS5HPGD
SCHEMBL7971963 0.84 MMP13 (0.77) MMP13MMP3CTSDMEN1KMT2A
SCHEMBL7971966 0.84 MMP13 (0.77) MMP13MMP3CTSDMEN1KMT2A
SCHEMBL7958249 0.84 MMP13 (0.70) MMP13MMP3CTSDADAMTS5HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251928-B1 ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0677517-A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D ELI LILLY AND COMPANY (US) 1995-10-18 EP disclosed